| |
| |
|
| Insider
Information: |
Saunders Brent L |
| Relationship: |
CEO and Chair, Director |
| City: |
Kenilworth |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
6,432,115 |
|
|
Indirect Shares
|
2,802,951 |
|
|
| Direct
Value |
$91,519,506 |
|
|
|
Indirect Value
|
$39,241,314 |
|
|
| Total
Shares |
9,235,066 |
|
|
| Total
Value |
$130,760,820 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -20.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Merck & Co Inc |
MRK |
Senior Vice President |
2009-11-03 |
0 |
2006-11-01 |
0 |
Premium* |
|
|
Allergan plc |
AGN |
Chairman, President an... |
2020-05-08 |
0 |
2014-07-01 |
0 |
Premium* |
|
|
Cisco Systems Inc |
CSCO |
Director |
2022-12-08 |
24,143 |
2017-03-13 |
0 |
Premium* |
|
|
Vesper Healthcare Acquisition Co... |
VSPRU |
Chairman, Director |
2023-08-16 |
5,827,453 |
2023-08-16 |
2,802,951 |
Premium* |
|
|
Bridgebio Pharma, Inc. |
BBIO |
Director |
2021-12-29 |
17,600 |
2021-12-29 |
0 |
Premium* |
|
|
Bausch & Lomb Corp |
BLCO |
CEO and Chair, Director |
2024-02-28 |
562,919 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BLCO |
Bausch & Lomb Corp |
CEO and Chair |
• • – |
2024-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
187,919 |
562,919 |
0 |
- |
|
| VSPRU |
Vesper Healthcare Acquisi... |
Chairman |
– • – |
2023-08-16 |
4 |
B |
$6.10 |
$362,372 |
D/D |
59,380 |
5,827,453 |
2.39 |
- |
|
| VSPRU |
Vesper Healthcare Acquisi... |
Chairman |
– • – |
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
16,357 |
5,768,073 |
0 |
- |
|
| BLCO |
Bausch & Lomb Corp |
CEO and ChairOfficer |
• • – |
2023-03-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
375,000 |
|
% |
|
| CSCO |
Cisco Systems Inc |
Director |
– • – |
2022-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,001 |
24,143 |
0 |
- |
|
| VSPRU |
Vesper Healthcare Acquisi... |
Executive Chairman |
– • – |
2022-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
194,031 |
5,751,716 |
0 |
- |
|
| VSPRU |
Vesper Healthcare Acquisi... |
Executive Chairman |
– • – |
2022-01-27 |
4 |
D |
$12.24 |
$83,379 |
D/D |
(6,812) |
5,557,685 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2021-12-29 |
4 |
B |
$14.48 |
$254,880 |
D/D |
17,600 |
17,600 |
2.39 |
% |
|
| CSCO |
Cisco Systems Inc |
Director |
– • – |
2021-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,180 |
32,503 |
0 |
- |
|
| VSPRU |
Vesper Healthcare Acquisi... |
Executive Chairman |
– • – |
2021-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
30,963 |
5,564,497 |
0 |
- |
|
| VSPRU |
Vesper Healthcare Acquisi... |
Executive Chairman |
– • • |
2021-05-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(11,500,000) |
0 |
0 |
- |
|
| VSPRU |
Vesper Healthcare Acquisi... |
Executive Chairman |
• • – |
2021-05-04 |
4 |
OE |
$0.00 |
$0 |
I/I |
11,500,000 |
11,500,000 |
0 |
- |
|
| CSCO |
Cisco Systems Inc |
Director |
– • – |
2020-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,189 |
27,543 |
0 |
- |
|
| AGN |
Allergan plc |
Chairman, President and CEO |
• • – |
2020-05-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(79,805) |
0 |
0 |
- |
|
| AGN |
Allergan plc |
Chairman, President and CEO |
• • – |
2020-05-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(149,384) |
0 |
0 |
- |
|
| AGN |
Allergan plc |
Chairman, President and CEO |
• • – |
2020-03-02 |
4 |
A |
$193.84 |
$13,299,944 |
D/D |
68,613 |
229,189 |
0 |
- |
|
| AGN |
Allergan plc |
Chairman, President and CEO |
• • – |
2019-12-31 |
4 |
D |
$191.17 |
$1,401,850 |
D/D |
(7,333) |
160,576 |
0 |
- |
|
| CSCO |
Cisco Systems Inc |
Director |
– • – |
2019-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,215 |
21,653 |
0 |
- |
|
| AGN |
Allergan plc |
Chairman, President and CEO |
• • – |
2019-04-05 |
4 |
D |
$145.71 |
$401,722 |
D/D |
(2,757) |
167,909 |
0 |
- |
|
| AGN |
Allergan plc |
Chairman, President and CEO |
• • – |
2019-03-07 |
4 |
B |
$142.18 |
$252,858 |
D/D |
1,760 |
170,666 |
2.81 |
- |
|
| AGN |
Allergan plc |
Chairman, President and CEO |
• • – |
2018-12-31 |
4 |
D |
$133.66 |
$1,238,895 |
D/D |
(9,269) |
168,906 |
0 |
- |
|
| CSCO |
Cisco Systems Inc |
Director |
– • – |
2018-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
4,744 |
16,014 |
0 |
- |
|
| AGN |
Allergan plc |
Chairman, President and CEO |
• • – |
2018-04-03 |
4 |
D |
$164.74 |
$454,023 |
D/D |
(2,756) |
178,175 |
0 |
- |
|
| AGN |
Allergan plc |
Chairman, President and CEO |
• • – |
2018-03-08 |
4 |
B |
$152.53 |
$503,349 |
D/D |
3,300 |
180,931 |
2.81 |
- |
|
| AGN |
Allergan plc |
Chairman, President and CEO |
• • – |
2017-12-29 |
4 |
D |
$163.58 |
$1,430,671 |
D/D |
(8,746) |
177,631 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
